Genetic engineering drugs has applications in research, medicine, agriculture, and industry and can be used on a broad range of plants, animals and microorganisms. In medicine, genetic engineering has been used to mass-produce human albumin, human growth hormones, follistim (for treating infertility), insulin, antihemophilic factors, monoclonal antibodies, vaccines, and many other drugs. In research, Organisms are genetically modified in experiments to learn more about the roles of specific genes. Transforming microorganisms such as bacteria or yeast, or insect mammalian cells with a gene coding for a useful protein, are examples of industrial applications. The protein can be produced in large amounts by fermenting the transformed organism in bioreactors and then purifying the protein.
Factors driving the growth of the genetic engineering drug market are the growing development of novel technologies in genome engineering, coupled with rising funding and investments for the development and research of new genetic engineering technologies. However, the high cost of genome engineering technology and needs high skilled researchers, which limits its adoption rate is expected to hamper the growth of the market. Moreover, increasing strategic collaboration for genome engineering drugs is anticipated to boost the market growth.
Unlock new opportunities in Global Genetic Engineering Drug Market; the latest release from The Insight Partners Research highlights the key market trends significant to the growth prospects, let us know if any specific players or list of players needs to consider to gain better insights.
Request for sample Report Copy @
Key Market Competitors: Global Genetic Engineering Drug Market
1. Shanghai Lansheng Guojian Pharmaceutical
2. Biotech Pharmaceutical
3. GeneScience Pharmaceuticals
4. Beijing SL Pharmaceutical
5. Anhui Anke Biotechnology
7. Jiangsu Sihuan Bioengineering
8. Tonghua Dongbao Pharmaceutical
9. Shenzhen Neptunus Interlong Bio-Technique
10. Others MARKET SEGMENTATION
The genetic engineering drug market is segmented on the basis of product type and end users. Based on product type, the market is segmented as monoclonal antibody, recombinant human erythropoietin, recombinant human interferon, recombinant human growth hormone, and recombinant human insulin. On the basis of end users, the market is categorized as pharmaceutical industries, academic institutes agriculture, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the genetic engineering drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The genetic engineering drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
Major Points from Table of Contents
1 Genetic Engineering Drug Market Overview
1.1 Genetic Engineering Drug Product Scope
1.2 Genetic Engineering Drug Segment by Type
1.2.1 Global Genetic Engineering Drug Sales by Type
1.3 Genetic Engineering Drug Segment by Application
1.3.1 Global Genetic Engineering Drug Sales Comparison by Application
1.4 Genetic Engineering Drug Market Estimates and Forecasts
1.4.1 Global Genetic Engineering Drug Market Size in Value Growth Rate
1.4.2 Global Genetic Engineering Drug Market Size in Volume Growth Rate
1.4.3 Global Genetic Engineering Drug Price Trends
2 Genetic Engineering Drug Estimates and Forecasts by Region
2.1 Global Genetic Engineering Drug Market Size by Region
2.2 Global Genetic Engineering Drug Retrospective Market Scenario by Region
2.2.1 Global Genetic Engineering Drug Sales Market Share by Region
2.2.2 Global Genetic Engineering Drug Revenue Market Share by Region
2.3 Global Genetic Engineering Drug Market Estimates and Forecasts by Region
2.3.1 Global Genetic Engineering Drug Sales Estimates and Forecasts by Region
2.3.2 Global Genetic Engineering Drug Revenue Forecast by Region
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Genetic Engineering Drug Estimates and Projections
2.4.2 Europe Genetic Engineering Drug Estimates and Projections
2.4.3 China Genetic Engineering Drug Estimates and Projections
2.4.4 Japan Genetic Engineering Drug Estimates and Projections
2.4.5 Southeast Asia Genetic Engineering Drug Estimates and Projections
2.4.6 India Genetic Engineering Drug Estimates and Projections
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Purchase Full Copy of This Report @
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defence.